Co-Authors
This is a "connection" page, showing publications co-authored by Brian Godman and Amanj Kurdi.
Connection Strength
2.546
-
A systematic review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 clinical outcomes: What is the evidence so far? Pharmacol Res Perspect. 2020 12; 8(6):e00666.
Score: 0.916
-
Evidence-based public policy making for medicines across countries: findings and implications for the future. J Comp Eff Res. 2021 08; 10(12):1019-1052.
Score: 0.239
-
Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries. Life (Basel). 2021 Jun 07; 11(6).
Score: 0.237
-
Changes in Availability, Utilization, and Prices of Medicines and Protection Equipment for COVID-19 in an Urban Population of Northern Nigeria. J Res Pharm Pract. 2021 Jan-Mar; 10(1):17-22.
Score: 0.236
-
Utilisation, Availability and Price Changes of Medicines and Protection Equipment for COVID-19 Among Selected Regions in India: Findings and Implications. Front Pharmacol. 2020; 11:582154.
Score: 0.231
-
Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications. Front Pharmacol. 2020; 11:588106.
Score: 0.231
-
Rapid Assessment of Price Instability and Paucity of Medicines and Protection for COVID-19 Across Asia: Findings and Public Health Implications for the Future. Front Public Health. 2020; 8:585832.
Score: 0.230
-
Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future. Front Pharmacol. 2020; 11:1205.
Score: 0.226